β³ Fetching live dividend data...
Home βΊ Calculator βΊ RXEI Dividend Calculator 2026
RxElite, Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RXEI β $1.0245121152153611e+41M in 10 years Β· $8,537,174,101,422,937,000,000,000,000,000,000,000,000,000,000.00/month
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. Its products include Sterile Liquid Dose products that consist of generic ophthalmic products in unit and multi-dose presentations, sterile unit dose inhalation respiratory products, and injectable drugs. The company, through its subsidiaries, also manufactures active pharmaceutical ingredients for pharmaceutical companies in the United States, Europe, and Asia. Its customers include hospitals and hospital group purchasing organizations, national and regional wholesalers, direct retail pharmacy stocking chains, homecare companies, and outpatient surgery centers and ambulatory care clinics. The company has partnership agreements with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; and Zach Systems S.p.A. RxElite is headquartered in Meridian, Idaho. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open RXEI position with:
Real after-tax yield depends on where you live and how you hold RXEI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1600000.00% | 1599997.20% | $160,000,000 / yr |
| π¬π§ UK ISA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 1825000.00% | 1824997.20% | $182,500,000 / yr |
| π¨π¦ TFSA | 0% | 2000000.00% | 1999997.20% | $200,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 1500000.00% | 1499997.20% | $150,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 1700000.00% | 1699997.20% | $170,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 1472500.00% | 1472497.20% | $147,250,000 / yr |
| π«π· FR Taxable | 30% | 1400000.00% | 1399997.20% | $140,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
RXEI pays quarterly β 4 times per year. Next ex-div: TBD.
How RXEI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RXEI sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RXEI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β